AI tool could help doctors ID breast cancers vulnerable to Enhertu
Bio Pharma Dive
MAY 22, 2025
Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.
Let's personalize your content